Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Legal Ruling Means Martin Shkreli Could Spend A Decade In Prison

Martin Shkreli will be responsible for $10.4 million in financial losses when he faces sentencing for defrauding hedge fund investors on March 9, 2018.

Read More »

DBV Reports Positive Data from Milk Allergy Trial

French company DBV Technologies said its Viaskin Milk product yielded successful results in a Phase II trial for patients suffering from IgE-mediated cow’s milk protein allergy.

Read More »

Roche’s hemophilia drug Hemlibra wins EU approval

Roche said the European Commission approved the Swiss Group’s drug Hemlibra for people with hemophilia A who have developed resistance to standard treatments.

Read More »

Aldeyra Therapeutics Inks Collaboration Deal with J&J

Aldeyra signed a collaboration research deal with Johnson & Johnson’s Janssen Research & Development to develop drugs that sequester pro-inflammatory aldehyde mediators.

Read More »

Twenty U.S. states sue federal government seeking end to Obamacare

A coalition of 20 U.S. states sued the federal government over Obamacare, claiming the law was no longer constitutional.

Read More »

Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta

Amgen today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency issued a positive opinion recommending a label variation for Neulasta (pegfilgrastim) to include the Neulasta Onpro Kit.

Read More »

Adscend Media to Host Webinar for Advertisers on Best Practices for Fighting Ad Fraud

Adscend Media will be hosting a webinar designed to help advertisers combat ad fraud. Titled, “Fighting Back Against Ad Fraud,” the hour-long webinar will provide strategies for desktop and mobile advertisers to minimize invalid traffic, using historical data from the Adscend platform. The free event also features a question and answer session with Adscend Media CEO Fehzan Ali, as well details on the company’s pioneering Total Fraud Defense technology.

Read More »

Leveraging HBA for Your Career and Company Performance

With the 2018 theme #PressForProgress, a Panel of HBA leaders was assembled to share practical examples of how they have leveraged their HBA experience — what they have learned and the relationships they have developed — to move the needle in their own careers and enhance their organization’s performance.

Read More »

Webinar to Reveal Data Supporting the Use of MuScreen for Preclinical Immunotherapeutic Development

Dr. Henry Li, a respected expert in preclinical pharmacology, will present a webinar showing data derived from CrownBio’s large-scale immunotherapy screening platform, MuScreen.

Read More »

Lilly breast cancer drug wins expanded U.S. approval

U.S. regulators approved expanded use of Eli Lilly and Co.’s Verzenio breast cancer drug as an initial treatment for certain women with advanced or metastatic disease.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom